Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis: Multiparameter analysis of disease including magnetic resonance imaging and bone mineral density measurements

Arthritis and Rheumatism

Volumn 39, Issue 3, 1996, Pages 504-514

  Bradbeer, Jeremy N ^a   Kapadia, Rasesh D ^a   Sarkar, Susanta K ^a   Zhao, Hugh ^a   Stroup, George B ^a   Swift, Barbara A ^a   Rieman, David J ^a   Badger, Alison M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 DIMETHYLAMINOPROPYL) 8,8 DIPROPYL 2 AZASPIRO[4.5]DECANE; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ATIPRIMOD; AZASPIRANE DERIVATIVE; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADJUVANT DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG STRUCTURE; DUAL ENERGY X RAY ABSORPTIOMETRY; HISTOLOGY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; DENSITOMETRY, X-RAY; INTERLEUKIN-6; JOINTS; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, INBRED LEW; SPIRO COMPOUNDS;

EID: 0029918814     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390319     Document Type: Article

References (25)

1. Badger AM, DiMartino MJ, Talmadge JE, Picker DH, Schwartz DA, Dorman JW, Mirabelli CK, Hanna N: Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes. Int J Immunopharmacol 11:839-846, 1989
2. Rabinovitch A, Suarez WL, Qin HY, Power RF, Badger AM: Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulating azaspirane, SK&F 106610. J Autoimmun 1:39-49, 1993
3. Albrightson-Winslow CR, Brickson BB, King A, Olivers D, Short B, Saunders C, Badger AM: Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. J Pharmacol Exp Ther 255:382-387, 1990
4. Hancock WW, Schmidbauer G, Badger AM, Kupiec-Weglinski JW: SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production, and prolongs rat cardiac allograft survival. Transplant Proc 24:231-232, 1992
5. Schmidbauer G, Hancock WW, Badger AM, Kupiec-Weglinski JW: SK&F 105685, a novel immunoregulatory azaspirane induces non-specific X-irradiation resistant suppressor cell activity in vivo and prolongs vascularized allograft survival. Transplantation 55:1236-1243, 1993
6. Fan P-Y, Albrightson-Winslow CR, Howell, D, Best C, Badger AM, Coffman TM: The azaspirane SK&F 105685 ameliorates renal allograft rejection in rats. J Am Soc Nephrol 3:1680-1685, 1993
7. High WB, Bugelski PJ, Nichols ME, Swift BA, Solleveld HA, Badger AM: Effects of a novel azaspirane (SK&F 105685) on the arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity. J Rheumatol 21:476-483, 1994
8. Badger AM, Swift BA, Bugelski PJ: Suppressor cell activity induces by the azaspiranes may reside in a non-adherent or semi-adherent tissue macrophage population (abstract). J Immunol 150:75A, 1993
9. Badger AM, Kupiec-Weglinski JW: Azaspiranes with therapeutic activity in animal models of autoimune disease and organ transplantation. In, New Immunosuppressive Modalities in Organ Transplantation. Edited by JW Kupiec-Weglinski. Austin, TX, RG Landes Company, 1994
10. Albrightson CR, Bugelski PJ, Berkhout TA, Jackson B, Kerns WD, Organ AJ, Badger AM: Separation of immunomodulatory and cholesterol lowering activities of heterocyclic azaspiranes. J Pharmacol Exp Ther 272:689-698, 1995
11. Weichman BM, Chau TT, Rona G: Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Arthritis Rheum 30:466-470, 1987
12. Conover WJ: Practical Nonparametric Statistics. Second edition. New York, John Wiley and Sons, 1980
13. Aarden LA, Lansdorp P, de Groot E: A growth factor for B-cell hybridomas produced by human monocytes. Lymphokines 10: 175-185, 1985
14. Badger AM, Swift BA, Webb EF, Bugelski PJ, Griswold DE: Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression. Int J Immunopharmacol 15:343-352, 1993
15. Badger AM, King AG, Talmadge JE, Schwartz DA, Picker DH, Mirabelli CK, Hanna N: Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. J Autoimmun 3:485-500, 1990
16. Badger AM, Schwartz DA, Picker DH, Dorman JW, Bradley FC, Cheeseman EN, DiMartino MJ, Hanna N, Mirabelli CK: Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents. J Med Chem 33:2963-2970, 1990
17. Kapadia RD, Adams JL, Badger AM, Sarkar SK: A magnetic resonance microscopy study to monitor dose response of two novel CSAID anti-inflammatory compounds in rat adjuvant arthritis. Presented at the Annual Meeting of the Society for Magnetic Resonance, August 19-25, 1995, Nice, France.
18. Houssiau FA, Devogelaer J-P, van Damme J, Nagant de Deuxchaisnes C, van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784-788, 1988
19. Swaak AJG, Rooyen A, van Nieuwenhuis E, Aarden LA: Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 17:469-474, 1988
20. Hirano T, Matsuda T, Turner M: Excessive production of IL-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797-1802, 1988
21. Badger AM, King AG, Talmadge JE, Schwartz DA, Picker DH, Mirabelli CK, Hanna N: Induction of non-specific suppressor cells in normal lewis rats by a novel azaspirane SK&F 105685. J Autoimmun 3:485-500, 1990.
22. Thiem PA, Kaplan JM, Bugelski PJ, Ruggieri EV, Badger AM: Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105685 in the dog. Immunopharmacology 23:67-74, 1992
23. Kaplan JM, Badger AM, Ruggieri EV, Swift BA, Bugelski PJ: Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog. Int J Immunopharmacol 15:113-123, 1993
24. King AG, Olivera D, Talmadge JE, Badger AM: Induction of non-specific suppressor cells and myeloregulatory effects on an immunomodulatory azaspirane, SK&F 105685. Int J Immunopharmacol 13:91-100, 1991
25. King AG, Badger AM: Administration of an immunomodulatory azaspirane, SK&F 105685 or human recombinant interleukin-1 stimulates myelopoiesis and enhances survival from lethal irradiation in C57BL/6 mice. Exp Hematol 19:624-628, 1991